Immune cell proliferation is suppressed by the interferon-γ-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG)

Journal of Cellular Biochemistry

Volumn 90, Issue 1, 2003, Pages 206-217

  Sarkhosh, Kourosh ^a   Tredget, Edward E ^a   Karami, Ali ^a   Uludag, Hasan ^a   Iwashina, Takashi ^a   Kilani, Ruhangiz T ^a   Ghahary, Aziz ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Fibroblasts; Indoleamine 2,3 dioxygenase (IDO); Interferon ; Skin substitute

Indexed keywords

COLLAGEN GEL; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; TRYPTOPHAN;

ARTICLE; CELL CULTURE; CELL ISOLATION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

ANIMALS; CATTLE; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; CULTURE MEDIA, CONDITIONED; FIBROBLASTS; GELS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; KYNURENINE; LEUKOCYTES, MONONUCLEAR; TRYPTOPHAN; TRYPTOPHAN OXYGENASE;

BOVINAE;

EID: 0042320822     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10593     Document Type: Article

References (37)

1. Alexander AM, Crawford M, Bertera S, Rudert WA, Takikawa O, Robbi PD, Trucco M. 2002. Indoleamine 2,3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 51(2):356-365.
2. Anderson P, Yip YK, Vilcek J. 1982. Specific binding of 125I-human interferon-gamma to high affinity receptors on human fibroblasts. J Biol Chem 257(19):11301-11304.
3. Anderson P, Yip YK, Vilcek J. 1983. Human interferon-gamma is internalized and degraded by cultured fibroblasts. J Biol Chem 258:6497-6502.
4. Bell E, Ivarsson B, Merrill C. 1979. Production of a tissue-like by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 76:1274-1278.
5. Billiau A, Dijkamans R. 1990. Interferon-γ: Mechanism of action and therapeutic potential. Biochem Pharmacol 40:1433-1439.
6. Boehm U, Klamp T, Groot M, Howard JC. 1997. Cellular responses to interferon-γ. Annu Rev Immunol 15:749-795.
7. Burke F, Knowles RG, East N, Balkwill FR. 1995. The role of indoleamine 2,3-dioxygenase in the anti-tumor activity of human interferon-gamma in vivo. Int J Cancer 60(1):115-122.
8. Cairns BA, deSerres S, Peterson HD, Meyer AA. 1993. Skin replacements. The biotechnological quest for optimal wound closure. Arch Surg 128(11):1246-1252.
9. Cheney IW, Lai VC, Zhong W, Brodhag T, Dempsey S, Lim C, Hong Z, Lau JY, Tam RC. 2002. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J Virol 76(21):11148-11154.
10. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18:5294-5299.
11. Dai W, Pan H, Kwok O, Dubey JP. 1994. Human indoleamine 2,3-deoxygenase inhibits Toxoplasma gondii growth in fibroblast cells. J Interferon Res 14(6):313-317.
12. Feng G, Taylor MW. 1989. Interferon γ-resistant mutants are defective in the induction of indoleamine 2,3-dioxygenase. Proc Natl Acad Sci USA 86:7144-7148.
13. Gallico GG, O'Connor NE, Compton CC, Kehinde O, Green H. 1984. Permanent coverage of large burn wounds with autologous cultured human epithelium. New Engl J Med 311(7):448-451.
14. Ghahary A, Shen Q, Rogers JA, Wang R, Fathi-Afshar A, Scott PG, Tredget EE. 1997. Liposome-associated interferon-alpha-2b functions as an anti-fibrogenic factor for human dermal fibroblasts. J Invest Dermatol 109(1):55-60.
15. Halloran PF, Afrouzian M, Ramassar V, Urmson J, Zhu LF, Helms LMH, Solez K, Kneteman NM. 2001. Interferon-γ acts directly on rejecting renal allografts to prevent graft necrosis. Am J Pathol 158:215-216.
16. Harrop AR, Ghahary A, Scott PG, Forsyth N, Uji-Friedland A, Tredget EE. 1995. Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma. J Surg Res 58(5):471-477.
17. Hayaishi O. 1996. Utilization of superoxide anion by indoleamine oxygenase-catalyzed tryptophan and indoleamine oxidation. Adv Exp Med Biol 398:285-289.
18. Heim MH. 1999. The Jak-STAT pathway: Cytokine signaling from the receptor to the nucleus. J Recept Sig Transduct Res 19:75-120.
19. Higuchi K, Hayaishi O. 1967. Enzymic formation of D-kynurenine from D-tryptophan. Arch Biochem Biophys 120(2):397-403.
20. Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA. 2000. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 164(7):3596-3599.
21. Kamimura S, Eguchi K, Yonezawa M, Sekiba K. 1991. Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta Med Okayama 45:135-139.
22. Leung BS, Stout LE, Shasken EG, Thompson RM. 1992. Differential induction of indoleamine 2,3-dioxygenase bi interferon γ in human gynecologic cancer cells. Cancer Lett 66:77-81.
23. Logan GJ, Smyth CM, Earl JW, Zaikina I, Rowe PB, Smythe JA, Alexander IE. 2002. HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase. Immunology 105(4):478-487.
24. Maza LM, Peterson EM. 1988. Dependence of the vitro antiproliferative activity of recombinant human γ-interferon on the concentration of tryptophan in culture media. Cancer Res 48:346-350.
25. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH. 2001. Prevention of T-cell driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2:64-68.
26. Mellor AL, Keskin DB, Johnson T, Chandler P, Munn DH. 2002. Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol 168:3771-3776.
27. Morhenn VB, Benike CJ, Charron DJ, Cox A, Mahrle G, Wood GS, Engleman EG. 1982. Use of the fluorescence-activated cell sorter to quantitate and enrich for subpopulations of human skin cells. J Invest Dermatol 79(5):277-282.
28. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL. 1998. Prevention of allogenic fetal rejection by tryptophan catabolism. Science 281(5380):1191-1193.
29. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189(9):1363-1372.
30. Ozaki Y, Edelstein MP, Duch DS. 1988. Induction of indoleamine 2,3-dioxygenase: A mechanism of the anti-tumor activity of interferon gamma. Proc Natl Acad Sci USA 85(4):1242-1246.
31. Rheinwald JG, Green H. 1975. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 6(3):331-343.
32. Sadir R, Lortat-Jacob H, Morel G. 2000. Internalization and nuclear translocation of IFN-γ and IFN-γ R: An ultrastructural approach. Cytokine 12(6):711-714.
33. Takikawa O, Yoshida R, Kido R, Hayaishi O. 1986. Tryptophan degradation in mice initiated by indoleamine 2, 3-dioxygenase. J Biol Chem 261:3648-3653.
34. Takikawa O, Kuriowa T, Yamazaki F, Kido R. 1988. Mechanism of interferon-γ action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-γ and evaluation of enzyme mediated tryptophan degradation in its anticellular activity. J Biol Chem 263(4):2041-2048.
35. Takikawa O, Habara-Ohkubo A, Yoshida R. 1990. IFN-γ is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection. J Immunol 145(4):1246-1250.
36. Thivolet J, Faure M, Demidem A, Mauduit G. 1986. Cultured human epidermal allografts are not rejected for a long period. Arch Dermatol Res 278(3):252-254.
37. Volpin D, Veis A. 1971. Isolation and characterization of the cyanogens bromide peptides from the α1 and α2 chains of acid-soluble bovine skin collagen. Biochemistry 10:1751-1755.